MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Advanced Ovarian Cancer

  1. Home
  2. Diseases
  3. Advanced Ovarian Cancer
  4. Clinical Trials

Clinical Trials Related to Advanced Ovarian Cancer

Related studies linked through entity extraction aliases.

NCT07648940

Bioequivalence Study of Liposomal Doxorubicin 20 mg/10 mL (Doxopeg® vs Caelyx®) in Advanced Cancer Patients

Status
COMPLETED
Phase
PHASE1

NCT07075939

Centralization and Oncologic Outcomes in Ovarian Cancer

Status
RECRUITING
Phase
N/A

NCT06997029

A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

Status
RECRUITING
Phase
PHASE1

NCT04862325

SOPHIE Trial: Surgery in Ovarian Cancer With PreHabilitation In ERAS

Status
COMPLETED
Phase
NA

NCT03737643

Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients

Status
ACTIVE_NOT_RECRUITING
Phase
PHASE3

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.